Taipei Exchange - Delayed Quote TWD
BioGend Therapeutics Co., Ltd. (6733.TWO)
26.30
+0.05
+(0.19%)
As of 9:21:59 AM GMT+8. Market Open.
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
-98,908
-98,908
-138,720
-168,781
-136,798
Investing Cash Flow
-8,199
-8,199
-89,636
201,701
-134,273
Financing Cash Flow
-3,641
-3,641
396,417
-4,810
287,846
End Cash Position
219,023
219,023
330,510
163,643
136,321
Capital Expenditure
-650
-650
-25,715
-18,177
-673
Issuance of Capital Stock
--
--
400,000
--
289,628
Free Cash Flow
-99,558
-99,558
-164,435
-186,958
-137,471
12/31/2021 - 6/18/2019
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
4726.TWO Mycenax Biotech Inc.
31.00
+1.47%
6712.TWO Ever Supreme Bio Technology Co., Ltd
168.00
+0.60%
6535.TWO Lumosa Therapeutics Co., Ltd.
157.50
+1.61%
6492.TWO Senhwa Biosciences, Inc.
32.55
+2.04%
7776.TWO Anya
29.80
-2.28%
4162.TWO PharmaEngine, Inc.
89.10
+1.60%
4911.TWO G&E Herbal Biotechnology Co., Ltd.
53.20
+1.14%
4130.TWO Genovate Biotechnology Co., Ltd.
20.35
+0.99%
4728.TWO Sunmax Biotechnology Co., Ltd.
445.00
+4.22%
6617.TWO Gongwin Biopharm Holdings Co., Ltd.
85.10
+2.65%